AggreSure ß-Amyloid (1-40), human - 0.25 mg
- Cat.Number : AS-72215
- Manufacturer Ref. :
- Shipping conditions : Ice delivery fees must be applied
AggreSure beta-Amyloid (1-40) peptide is pretreated and tested for aggregation using SensoLyte® ThT Aβ40 Aggregation kit (Cat# AS-72213). Aggregation is guaranteed. The quantity is 0.25mg net peptide.
Alzheimer's Disease (AD) is the most common neurodegenerative disorder in elderly people. It has been demonstrated that AD has biological causes and is characterized by the presence of senile plaques and neurofibrillary tangles mainly in cerebral cortex and hippocampus brain regions. Beta-Amyloid (1-40) (Aβ40) and beta-Amyloid (1-42) (Aβ42) are the main components of the above plaques; however, other forms of beta-Amyloid peptides are also present. Both peptides are cleaved from the Amyloid Precursor Protein (APP) by β-secretase and ?-secretase enzymes. Many studies suggest that Aβ42 or/and Aβ43 are required to initiate formation of amyloid plaques and neurofibrills that leads to the neurodegeneration, while Aβ40 is less neurotoxic.
|Sequence one letter code||
|Sequence three letter code||
|CAS registry number||
|Molecular Mass/ Weight||
|Quantity & Purity|
|Storage & stability|
|Sub-category Research Area|
|Source / Species||
You may also be interested in the following product(s)
Enantiomeric Aβ peptides inhibit the fluid shear stress response of PIEZO1
Nature . 2018 Sep 24 ; 8 14267 | DOI : 10.1038/s41598-018-32572-2
- MM. Maneshi
- et al
Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.
J Neurosci. . 2016 Feb 01 ; 36(6) 1930 | DOI : 10.1523/JNEUROSCI.0350-15.2016
- AM. Hartz
- et al
Effects of Melatonin and Beta-Amyloid on Mitochondrial Function in a Model of Aging Mouse Astrocytes.
FASEB J . 2016 Apr 18 ; 702,1
- EK. Debner
- JM. King